Although telomere instability is observed in human tumors and is associated with the development of cancers in mice, it has yet to be established that it can contribute to the malignant transformation of human cells. We show here that in checkpoint-compromised telomerase-positive human fibroblasts an episode of TRF2 inhibition promotes heritable changes that increase the ability to grow in soft agar, but not tumor growth in nude mice. This transforming activity is associated to a burst of telomere instability but is independent of an altered control of telomere length. Moreover, it cannot be recapitulated by an increase in chromosome breaks induced by an exposure to cradiations. Since it can be revealed in the context of telomerase-proficient human cells, telomere dysfunction might contribute to cancer progression even at late stages of the oncogenesis process, after the telomerase reactivation step.
Introduction
Telomeres are a key feature of linear chromosomes that preserve genome stability, and their modifications are suspected to play a major role in cancer (Artandi and DePinho, 2000) . They are composed of short tandem repeated DNA sequences, and various telomere-associated proteins (McEachern et al., 2000) . The maintenance of telomere length depends on telomerase, a specialized reverse transcriptase that replicates telomeres (Greider and Blakburn, 1985) . Telomerase is a ribonucleoprotein complex that uses its RNA template to add G-rich telomeric repeats to the terminal 3 0 overhang. Telomerase expression is regulated during development, being expressed in germ cells and in certain somatic stem cell lineages, but being either absent or expressed at very low levels in adult somatic cells (Shay, 1997; Masutomi et al., 2003) . The fine regulation of telomerase expression in adult somatic cells imposes a proliferation barrier that seems to act as a tumorsuppressor mechanism (Lin and Elledge, 2003) .
Telomeric proteins are essential to preserve chromosome stability by controlling telomere length, recombination and DNA damage checkpoint (Marcand et al., 1997; Ferreira and Cooper, 2001 ). For instance, in human cells the telomeric TTAGGG repeat binding factor 2 (TRF2) protects telomere from being repaired by nonhomologous end-joining and recognized as DNA damage by ATM (Karlseder et al., 2004) . Accordingly, TRF2-depleted telomeres appear deprotected and can undergo endto-end fusions and subsequent chromosome abnormalities.
When telomeric DNA is reduced to a critical threshold length or when telomere structure is damaged, cells enter senescence or undergo apoptosis (Bodnar et al., 1998; van Steensel et al., 1998; Karlseder et al., 1999 Karlseder et al., , 2004 . In the absence of both the p53 and the Rb pathways, dysfunctional human telomeres do not constitute a barrier to proliferation and the cells accumulate karyotypic changes due to inappropriate telomere recombination and dicentric formation (Counter et al., 1992; .
Both in vitro and in vivo, overexpression of telomerase in cancer cells appears to be crucial for tumor progression (Greenberg et al., 1999; Hahn et al., 1999a, b; Gonzalez-Suarez et al., 2000 Elenbaas et al., 2001; Artandi et al., 2002) . On the other hand, studies on mice lacking the telomerase RNA gene demonstrate that critical telomere shortening and telomere instability can favor initial stages of cancer formation and cooperates with p53 deficiency to favor carcinogenesis Rudolph et al., 2001) . In human tumorigenesis, a burst of telomere instability could occur at early stages as a consequence of an excessive telomere shortening and checkpoint inactivation (Rudolph et al., 2001; O'Sullivan et al., 2002; Chin et al., 2004; Zhang et al., 2004) . This scenario is in agreement with the increased tumor susceptibility of patients carrying mutations in genes involved in chromosome stability and telomere maintenance (Callen and Surralles, 2004) . In addition, studies on human tumors suggest a link between telomere dysfunction, chromosome instability and cellular transformation (Gisselsson et al., 2001) . However, until now, a study to assess in human cells the transforming activity promoted by telomere instability has not been performed.
We used human foreskin BJ fibroblasts immortalized with telomerase and expressing the early region of the SV40 virus, compromising the p53 and p16/Rb pathways and thus allowing the cycling of cells exhibiting telomere deprotection (Hahn et al., 1999a) . These cells are not transformed and require the expression of additional oncogenic factors, such as a constitutively active form of the Ras protein (Ha-Ras V12), to become transformed and tumorigenic (Hahn et al., 1999a) . To induce telomere dysfunction, we generated a set of isogenic cell lines stably expressing different TRF2 mutant forms by retroviral transduction. We observed a close correlation between a transient episode of telomere instability due to TRF2 inhibition and the emergence of heritable changes that promote anchorage-independent growth but not tumor growth. These findings support the idea that an episode of telomere instability contributes to the emergence of some of the events leading to the malignant transformation of checkpoint-deficient human cells.
Materials and methods

Constructs and cell lines
The details on the DNA constructs generated during this study will be given upon request. BJ fibroblasts expressing hTERT and SV40 early region (BJ-EHLT 11147, hereafter SV40-T BJ) were supplied by R Weinberg (Whitehead Institute for Biomedical Research) (Hahn et al., 1999a) . All SV40-T BJ derivatives were cultured in Dulbecco's Modified Eagle's Medium (DMEM, Invitrogen) supplemented with 10% heat-inactivated fetal calf serum (Invitrogen), 400 mg/ml G418 for neomycin, 100 mg/ml for hygromycin, at 371C in an atmosphere of 5% CO 2 in air. The amphotropic Phoenix packaging cell line was supplied by R Iggo (ISREC) and was cultured in DMEM supplemented with 10% heatinactivated fetal bovine serum at 371C in an atmosphere of 5% CO 2 in air.
To evaluate the growth properties of the SV40-T BJ derivatives, at each time point 2 Â 10 5 cells were plated in 100 mm dishes in the above-mentioned culturing medium. Cells were then counted at the indicated time intervals.
Retroviral infections
To create amphotropic retroviruses, 10-cm dishes of Phoenix amphotropic packaging cells were transfected with 10 mg each of the specified pBabe retroviral expression construct (Morgenstern and Land, 1990) by calcium phosphate precipitation. Viral supernatants were harvested at 24 h after transfection and used to infect SV40-T BJ fibroblasts with 8 mg/ml polybrene. Fresh medium was added to the packaging cells and 12-18 h later viral supernatants were collected a second time to super infect the SV40-T BJ fibroblasts with 8 mg/ml polybrene. Drug selection of retrovirally transduced cells was started 48 h after second infection supplementing the culture medium with puromycin at 0.5 mg, final concentration. Cells were kept in selecting medium throughout the course of each experiment.
Immunological detections
Anti-Myc tag antibody 9E10 (M5546) and anti-actin (A5441) were from Sigma. Anti-TRF2 antibody has been described previously (Bilaud et al., 1997) . Retrovirally transduced SV40-T BJ derivatives were grown on eight-well chamber slides. Cells were fixed with methanol/acetone (1:1) and the Myctagged proteins were detected using the 9E10 monoclonal antibody (Sigma).
Metaphase chromosome analysis
Metaphase chromosomes were fixed overnight in methanol/ acetic acid (3:1 vol/vol). Telomere analysis was performed as previously described (Lansdorp et al., 1996) using PNA probes labeled with Cy3 (Perseptive Biosystems). Centromeres were hybridized with Cambio probes. Multiplex fluorescence in situ hybridization (M-FISH) analyses was performed using multi-FISH probes (MetaSystems, GmbH) according to the manufacturers' recommendations. Images of hybridized metaphases were captured with a CCD camera (Zeisss) coupled to a Zeiss Axioplan microscope and were processed with ISIS software (MetaSystems, GmbH).
Soft-agar growth
At the time of plating in soft agar, cultures were trypsinized and counted, and 2 Â 10 4 total cells were mixed with 1.5 ml of 0.45% low melting point (LMP) agarose-DMEM (top layer) and then poured on top of 1.5 ml of solidified 0.75% LMP agarose-DMEM (bottom layer) in six-well plates. Colonies were counted and photographed after 5 weeks.
Subcutaneous tumorigenicity assays
Immunocompromised athymic nude female mice (Swiss nu/nu nude) 4-week old were obtained from Iffa Credo, France. Animals were injected within 1 week. At 24 h prior to injection, animals were irradiated with 4 Gy using a 137 Cs source at a dose rate of 0.71 Gy/min (IBL 637, CIS Biointernational). Irradiation was performed to suppress natural killer cell activity (Feuer et al., 1995) and/or to favor the growth of tumor cells (Barcellos-Hoff and Ravani, 2000) . Cells (5 Â 10 6 ) were resuspended in 200 ml of phosphate-buffered saline solution and injected into anaesthetized mice. The different SV40-T BJ derivative lines expressing the various TERF2 alleles or the empty vector were injected into at least five animals for each experiment. SV40-T BJ cells expressing the HA-RAS V12 allele were used as control for tumor formation (Hahn et al., 1999a) . The size of the tumor, when present, was measured twice a week. Mice were killed when the tumors grew to 1 cm in diameter or after 24 weeks of monitoring. Animals were treated in a human manner in accordance with the European Union guidelines for the animal laboratory care and use.
Results
Induction of different types of TRF2 dysfunction in telomerized BJ fibroblasts
The parental cells used in the course of this study are the human foreskin BJ fibroblasts expressing the catalytic subunit of the human telomerase protein (hTERT) and the SV40 large T and small t antigens, designated hereafter as SV40-T BJ fibroblast (Hahn et al., 1999a) . These cells are immortalized and can be transformed by ectopic expression of an activated Ras allele (Ha-Ras V12) (Hahn et al., 1999a) . After infection of SV40-T BJ fibroblasts with a set of retroviruses carrying different Myc-tagged TERF2 alleles (M-TERF2, see Figure 1a ), polyclonal populations were established in selective medium. The expression of these alleles was followed by Western blot (Figure 1b (Figure 2a) . Such a growth phenotype was already observed in a similar cellular setting or when telomere dysfunction is induced in mouse liver (Lechel et al., 2005) . Immunofluorescence studies of the number of cells expressing the Myc-tagged TRF2 protein show that the percentage of M-TRF2
DBDM -positive cells does not decrease when the cells regain their full growth capacity ( Supplementary Figure 1) , suggesting a progressive selection of cells poorly expressing the transgene.
To assay the telomeric damages induced by the transduced M-TERF2 alleles, we measured telomere length and telomere association (TA). As expected (Ancelin et al., 2002; Karlseder et al., 2002; Wang et al., 2004) , full length M-TRF2 and to a much greater extent the M-TRF2 DB protein induce telomere shortening upon cell growth (Supplementary Figure 2) . Notably, M-TRF2 DB -expressing cells show an increase in the number of very short telomeres, as deduced from the large smear observed in the telomere length blot (Supplementary Figure 2) . However, we do not observe any growth defect or increase in TA in these cells (Figure 2a) , suggesting that the telomeres generated during the time course experiments (up to 100 days p.i.) preserve most of their protective functions. However, we cannot exclude that some of these very short telomeres give rise to dicentric chromosomes unable to produce an interstitial telomeric signal (ITS), thus escaping from the TA analysis. It is noteworthy that the shortening in M-TRF2 DB cells appears to break after 50 days p.i. (Supplementary Figure 2) , which is likely to result either from a decrease in the expression of the M-TRF2 Transformation promoted by telomere dysfunction M Brunori et al protein (Figure 1 ) or from a preferred telomerase lengthening of critically short telomeres (Marcand et al., 1999; Teixeira et al., 2004) or both. The expression of M-TRF2 DBDM leads to a modest but significant telomere lengthening (Supplementary Figure 2) , which might reflect a decreased number of TRF1 or TRF2 molecules at chromosome ends (Smogorzewska et al., 2000; Colgin and Reddel, 2004) .
In three independent infection experiments, we notice that the expression of M-TRF2 DBDM or M-TRF2 Figure 2a and b) . The level of chromosome anomalies (dicentric, radian, ring, chromatid and chromosome breaks that do not involve an ITS, see Figure 2b ), named hereafter 'global instability', appears roughly similar between cells expressing the different M-TRF2 forms, indicating that both M-TRF2
DBDM and M-TRF2 DM proteins induce telomere-specific damages (Figure 2b and c) . The absence of modification in chromosome number and morphology due to Ha-Ras V12 expression or TRF2 inhibition (Figure 2c and data not shown) does not exclude the appearance of more subtle chromosome instability. Indeed, the same HA-RAS allele was previously reported to increase the intracellular level of reactive oxygen species in human fibroblasts, which could trigger various types of DNA damage . Of note, human oncogenic HA-RAS alleles were reported to induce genomic instability in certain cell types (see for example (Denko et al., 1994; Woo and Poon, 2004) but not in others , as in our case with human fibroblasts (Figure 2 ). The reason of these discrepancies are not known but could rely on cell-type differences, culture conditions and/or levels of Ras activation. Finally, we do not observe any change in the mRNA levels of the endogenous TERF2 gene as well as other genes involved in telomeric functions (TERF1, TINF2, RAP1, PinX1 and POT1), as measured by quantitative RT-PCR in both short-and long-term cultures (data not shown).
We therefore conclude that M-TRF2
DM -and M-TRF2
DBDM -expressing cells can be used to compare the effects of two different degrees of telomere instability while M-TRF2 DB -expressing cells are representative of a distinct telomere dysfunction, characterized by a rapid shortening of telomeres that still maintain their protective functions. Unexpectedly, these findings unveil that deletion of the basic domain is synergistic to the removal of the DNA-binding domain on the dominant-negative activity of the M-TERF2 DBDM allele. Since both proteins appear to be expressed at similar level, at least during the first two weeks p.i., this could be due to a more efficient removal of M-TRF2 DBDM from the telomere or to a protective activity of the B domain when telomeres contain a limited amount of TRF2.
Expression of M-TRF2
DBDM promotes anchorageindependent growth of SV40-T BJ fibroblasts We then measured the ability of the different M-TERF2 alleles to induce cell growth in an anchorage-independent manner, a hallmark of neoplastic transformation. The SV40-T BJ fibroblasts expressing the different alleles were plated in soft agar and colony formation was monitored. Colonies were counted after 5 weeks and quantitative data from five independent infection experiments are presented in Figure 3 . A background level of small colonies is seen with cells infected with the empty vector, usually less than five per 10 000 cells seeded. We observe a significant increase both in the number and in the size of colonies of cells infected with M-TERF2 DBDM vector as compared to cells infected with the empty vector (Figure 3a and b) . In contrast, cells DM or M-TRF2 DB or M-TRF2 vector do not lead to a greater extent of colony formation ( Figure 3b) . As positive control, we used the same cells infected with a vector expressing Ha-Ras V12. These cells rapidly form a high number of large colonies (Figure 3a and b) , in accordance with published observations (Hahn et al., 1999a) . When compared to Ha-Ras V12 transformed cells, the efficiency of colony formation with cells infected with M-TERF2 DBDM vector is lower, the colonies are generally smaller in size and they appear after a longer incubation period (Figure 3a , data not shown). Unfortunately, we were unable to assay for the stability of this phenotype since we failed to maintain cell lines established from soft-agar clones derived from the population of M-TRF2 DBDM -expressing cells.
Expression of the M-TRF2 DBDM protein does not confer any advantage in plating efficiency on plastic dishes when compared to the other mutant proteins and Ha-Ras V12 (Figure 3c ), indicating that the increased colony formation in semisolid medium conferred by this allele is mainly the consequence of its ability to grow in an anchorage-independent manner. Finally, cells expressing the different mutated forms of TRF2 are not able to form colonies on dishes when grown in low-serum conditions (Supplementary Figure 3) . This contrast with cells expressing Ha-Ras V12 that grow under limiting serum condition, in agreement with previous studies (Hahn et al., 2002) .
We next examined whether the slight telomere lengthening associated to M-TRF2 DBDM expression (Supplementary Figure 2) could account for the increased ability to grow in soft agar. We do not observe an increase in colony formation in soft agar when the SV40-T BJ cells were transduced with a lentivirus containing hTERT and causing a telomere over-elongation (data not shown). These results demonstrate that the anchorage-independent growth induced by M-TRF2
DBDM cannot be attributed to the increase in telomere length of the cell population.
Overall, we conclude that the expression of the M-TRF2
DBDM allele leads to a mild transformed phenotype, exhibiting an increased capacity to grow in an anchorage-independent manner but unable to evade growth factors requirement.
TRF2 inhibition drives clonal changes that promotes anchorage-independent growth
The ability of the M-TRF2 DBDM cells to show a higher efficiency of colony formation in soft agar peaks at approximately 20 days p.i. (Figure 3b ). Strikingly, it remains significantly higher than empty vector control in long-term cultures, even 100 days p.i. when the mutant protein is undetectable by immunoblotting, immunofluorescence and mRNA quantification (Figure 1b and data not shown). These results suggest that a transient expression of M-TRF2 DBDM can lead to one or several heritable change(s) that promote anchorage-independent growth. In order to investigate this possibility, we studied the malignant properties of clonal populations of cells expressing the different M-TRF2 forms. Three out of 11 clones derived from the infection with the M-TERF2
DBDM and M-TERF2 DM vectors show a frequency of colony formation in soft agar much higher than the corresponding polyclonal population (8-, 15-and 21-folds increase, respectively, for clones M3, BM2 and BM6; Table 1 ). In contrast, none of the 12 clones derived from the empty control, retroviral infection with the M-TERF2 and M-TERF2
DB vectors shows such an increase in colony formation in soft agar (Table 1) promote an anchorage-independent growth phenotype ( Figure 3) . Moreover, this phenotype can be clonally propagated after the burst of expression of the two alleles that lead to telomere instability. In agreement with a causal link between telomere instability and anchorage-independent growth, the more effective TERF2 allele regarding telomere instability gives rise to clones with the highest colony-formation efficiency (Table 1) . There is no correlation between the expression of the TRF2 mutated forms and the ability of the clone efficiency in soft agar (Table 1 ). In fact, the two clones that give rise to the higher plating efficiency express either very low or undetectable amount of the M-TRF2 DBDM protein (see clones BM2 and BM6, respectively, Table 1 ). In contrast, some clones expressing high levels of M-TRF2 DBDM do not show an increase in colony formation in soft agar (see clones BM1, BM4 and BM8, Table 1 ). Of note, these clones do not show any additional sign of 'ongoing' telomere instability, as deduced from the lack of detectable TA (data not shown). How these cells become resistant to a long-term expression of the M-TRF2 DBDM protein is presently unknown, but could be related to a mutation in the M-TERF2
DBDM cDNA or to a transition in the structure of the telomeres. Overall, we conclude that a transient M-TRF2 DBDM expression is sufficient to drive heritable changes promoting anchorage-independent growth. M-FISH analyses establish that each clone presents different chromosome rearrangements, both clonal, that is, shared by at least two cells, or nonclonal revealing a certain level of 'on-going' chromosome instability within the clonal population of cells (data not shown). We were unable to detect any gross chromosomal abnormality (translocation, chromosome imbalance, ploı¨dy, etc.) that would have been specific of the two clones showing the highest plating efficiency (clones BM2 and BM6, Table 1 and data not shown).
Finally, we show that a single exposure to g-rays leading to an increased global chromosome instability is not sufficient to promote anchorage-independent growth of SV40-T BJ fibroblasts (Supplementary Figure  4) . Therefore, it emerges that the heritable changes responsible for the anchorage-independent capacity may be dependent upon the quality of damage elicited upon TRF2 inhibition, such as end-to-end fusion or loss of telomere integrity.
TRF2 inhibition is not sufficient to fully transform immortalized fibroblasts
We next asked whether the expression of the various M-TERF2 alleles can be tumorigenic in mice. In two independent experiments, early (18 days p.i.) and late (100 days p.i.) polyclonal culture cells were injected subcutaneously and mice were weekly monitored for tumor formation during 6 months. None of the TRF2 alleles is able to induce tumor formation in nude mice up to 6 months after injection (Figure 3b ). In addition, autopsies of the injected mice reveal no gross morphological differences among animals injected with cells expressing different M-TRF2 forms. As positive control, SV40-T BJ cells expressing Ha-Ras V12 were also injected and the mice developed tumors with a high frequency (Figure 3b ), in agreement with previous results (Hahn et al., 1999a) . The eventual lag in the outgrowth of tumors in these mice could be related to the levels of oncogenic Ras as shown in similar published studies (Elenbaas et al., 2001 ). In addition, we performed similar experiments using the M-TRF2 DBDM -expressing clonal cell populations that showed the highest number of colony formation in soft agar. None of the different cell lines gave rise to tumors when injected in subcutaneous mice, in agreement with the behavior of the polyclonal cell populations (Table 1) .
Discussion
The main conclusion of the study presented here is the demonstration of a relationship between telomere instability and human cell transformation. First, TRF2 inhibition increases the ability of checkpoint-compromised human fibroblasts immortalized by telomerase to form colonies in soft agar, one of the hallmark properties of in vitro transformed and cancer cells. Second, this capacity does not depend upon a prolonged inhibition and can be clonally propagated, suggesting that a transient loss of TRF2 is sufficient to promote transformation. Third, neither a rapid telomere shortening nor a telomere overelongation can transform the same cells, indicating that the transforming activity of TRF2 inhibition is not mechanistically linked to telomere length changes. E3 E4 E5 F1  F3  B2 B3 B5 B6 B8 B9 M2 M3 M5 BM1 BM2 BM3 BM4 BM5 BM6 BM7 c Ability to form colonies in soft agar, normalized to the respective polyclonal population of infected cells cultured in parallel; the soft-agar assay was determined in triplicate samples and the standard deviation does not exceed 20%.
Transformation promoted by telomere dysfunction M Brunori et al Four out of four clones derived from cells that have experienced TRF2 inhibition show a different pattern of clonal chromosome aberrations as analyzed by M-FISH, indicating that the cells that survived the episode of telomere instability and that exhibit a higher ability to grow in soft agar are still polyclonal. This, together with the fact that we have been unable to derive transformed clones from control cells, argue against the hypothesis that TRF2 inhibition selects for preexisting transformed cells. Rather, we propose that TRF2 inhibition promotes genetic or epigenetic changes involved in anchorage-independent growth. These changes are likely to be a consequence of the episode of telomere instability as either the expression of the M-TERF2 DB allele, leading to rapid telomere shortening but not to telomere instability, or of the M-TERF2 DM allele, that causes only a faint increase in telomere instability, exhibit no or limited transforming activity, respectively.
If TRF2 inhibition confers to cells the ability to grow in semisolid medium, however, it does not seem sufficient for full transformation, as these cells do not grow in low serum and do not form tumors in vivo. We believe that it is unlikely that fully transformed cells appear in the polyclonal population but are not enriched enough in the cells injected in nude mice because clones that show a marked increase in anchorage-independent growth do not give rise to tumors (Table 1) . Therefore, additional changes, which are required for tumor formation in vivo, do not seem to be favored by TRF2 dysfunction, at least in the fibroblast and mouse models used here. Indeed, the immortalized cell line utilized in this study can form tumors in vivo only when expressing high levels of the Ha-RasV12 oncogene (Rangarajan et al., 2004) . Such a dissociation between the ability to grow in soft agar and to form tumor is not unprecedented (Hamad et al., 2002) and is consistent with the fact that the transforming activity of M-TRF2 DBDM is not as effective as Ha-Ras V12 (Figure 3a and b) . Nevertheless, TRF2 inhibition appears to be more potent at conferring an anchorage-independent growth phenotype than an exposure to g-radiation, even at doses exhibiting a marked impact on cell growth and chromosome stability. We conclude that, whereas TRF2 inactivation is not alone sufficient for tumorigenic growth, it can generate changes involved in human cell transformation. The nature of these changes can be genetic, such as chromosome rearrangements provoked by end-to-end fusions, or epigenetic, such as altered telomere position effects (Baur et al., 2001; Koering et al., 2002) . Of note, we found no evidence by M-FISH analysis of chromosome rearrangements shared by the clones having experienced TRF2 inactivation and leading to a high level of colony formation in soft agar. Strikingly, our results unveil a transforming role for telomere dysfunction in the context of cells expressing telomerase and maintaining the length of their telomeres. Therefore, telomerase overexpression and telomere length maintenance might not be the sole telomere changes involved in human oncogenesis. Other type of telomere dysfunction, in particular, an improper structure of the telomeric chromatin, might favor the progression of tumor, even at late stages of oncogenesis. In agreement with this idea, a downregulation of the TERF2 mRNA has been observed in tumors (Miyachi et al., 2002; Yamada et al., 2002a, b) (MB, QW, AP and EG, unpublished observations). On the contrary, TRF2 was also shown to be upregulated in some human carcinomas (Nakanishi et al., 2003; Oh et al., 2005) . Our results suggest that this might act as a shield against telomere instability and tumor progression. Interestingly, TRF2 overexpression might also play other antitumor functions as in DNA damage response (Klapper et al., 2003; Bradshaw et al., 2005) .
Overall, our data suggest that the conversion of normal human cells into cancer cells or the evolution of a cancer to a more aggressive state can be promoted by episodes of telomere dysfunction. Whether the transforming activity revealed here for human fibroblasts holds true for other types of cell, in particular of epithelial origin, can now to be tested using the experimental strategy developed in this study. Our findings highlight the value of exploring the overall telomere organization in clinical oncology and suggest that factors involved in telomere protection could represent new markers for cancer evolution.
